| |
|
|
|
Harvard Bioscience Inc.  
|
|
2.77 -0.08 (-0.03%) |
10-16 16:00 |
|
Open: |
2.85 |
Pre close: |
2.85 |
Target:
|
3.69
|
|
High: |
2.91 |
Low: |
2.76 |
Resistance:
|
3.16
3.50
|
|
Volume: |
35,442 |
Market Cap: |
105M |
Support:
|
2.60
2.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.81
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
3.05 |
Signal(12,26,9): |
0.04 |
|
MA(100): |
2.44  |
Stochastic Oscillator |
%K(14,3):
|
26.92 |
|
MA(250): |
3.15 |
%D(3): |
18.92 |
|
Average Volume(K) |
3-Month: |
28320
|
52-Week |
High:
|
4.74 |
|
10-Days: |
7333 |
Low: |
1.51 |
|
RSI |
RSI(14):
|
43.31 |
Change(%): |
-40.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.000 |
Return on Equity (ttm) |
0.6 |
Shares Out. (M) |
38.05 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
1.4 |
Shares Float (M) |
28.59 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
1.54 |
% Held by Insiders |
12.87 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
-6.1 |
% Held by Institutions |
74.11 |
|
Forward EPS |
0.260 |
Gross Profit (p.s.) |
1.760 |
Shares Short (K) |
1230 |
|
Book Value (p.s.) |
2.120 |
EBITDA (p.s.) |
0.310 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.31 |
|
Profit Margin |
-0.01 |
Operating Cash Flow
(M) |
3.83 |
P/S |
32834422.00 |
|
Operating Margin |
3.14 |
Levered Free Cash Flow
(M) |
5.01 |
P/CF |
27.52 |
|
|
|
|
|
|
